首页|血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值

血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值

扫码查看
目的 分析血清转化生长因子β1(TGF-β1)、血管内皮生长因子(VEGF)对非小细胞肺癌(NSCLC)患者单孔胸腔镜根治术后复发的预测价值.方法 选取徐州医科大学附属医院2018年5月至2020年5月就诊的50例行单孔胸腔镜根治术治疗的NSCLC患者为研究对象,比较手术前后血清TGF-β 1、VEGF水平、Karnofsky功能状态(KPS)评分,统计并发症总发生率.对所有研究对象进行为期3年的随访,比较复发组与未复发组、存活组与死亡组患者的血清TGF-β1、VEGF水平及KPS评分,采用Pearson相关分析探讨TGF-β1、VEGF与KPS评分的相关性.绘制受试者操作特征(ROC)曲线,计算曲线下面积(AUC),评估血清TGF-β1、VEGF单独及联合检测对NSCLC患者单孔胸腔镜根治术后复发的预测价值.结果 50例NSCLC患者单孔胸腔镜根治术后1个月血清TGF-β1水平为(7.16±1.94)μg/L、VEGF水平为(42.26±5.04)ng/L,均低于术前的(13.62±3.52)μg/L、(136.52±20.66)ng/L(t=11.37,P<0.001;t=31.34,P<0.001);术后 1 个月 KPS评分为(66.57±8.11)分,高于术前的(53.62±5.62)分(t=9.28,P<0.001).50例患者术后1例发生切口延迟愈合、1例肺部感染,无肺栓塞等其他并发症发生,并发症总发生率为4.00%.复发组(n=6)患者的血清TGF-β1水平为(12.95±4.26)μg/L、VEGF水平为(72.46±6.05)ng/L,均高于未复发组(n=44)的(6.37±1.25)µg/L、(38.14±5.37)ng/L(t=8.34,P<0.001;t=29.99,P<0.001);复发组患者的 KPS 评分为(52.16±8.16)分,低于未复发组的(67.55±12.67)分(t=2.88,P=0.006).死亡组(n=5)患者的血清TGF-β1 水平为(13.99±6.82)µg/L、VEGF 水平为(75.95±9.05)ng/L,均高于存活组(n=45)的(6.41±3.06)μg/L、(38.52±8.37)ng/L(t=4.56,P<0.001;t=21.47,P<0.001);死亡组患者的 KPS 评分为(1.25±0.34)分,低于存活组的(65.11±12.94)分(t=10.93,P<0.001).Pearson相关分析显示,血清TGF-β1(r=-0.45,P<0.001)、VEGF(r=-0.48,P<0.001)水平均与KPS评分呈负相关.ROC曲线分析显示,TGF-β1最佳截断取值8.14 μg/L时,对单孔胸腔镜根治术后复发预测的AUC为0.516(95%CI为0.446~0.676),敏感性为71.85%,特异性为 80.69%;VEGF最佳截断取值 142 ng/L 时,AUC 为 0.659(95%CI为 0.534~0.761),敏感性为 76.04%,特异性为82.52%;两者联合检测的AUC为0.828(95%CI为0.786~0.951),敏感性为91.86%,特异性为87.52%;两者联合检测的AUC优于TGF-β1、VEGF单独检测(Z=2.63,P=0.007;Z=2.32,P=0.013).结论 NSCLC患者行单孔胸腔镜根治术治疗1个月后,血清TGF-β1、VEGF水平明显降低,两者联合检测对单孔胸腔镜根治术后复发具有较高的预测价值.
Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection
Objective To analyze the predictive value of serum transforming growth factor-β1(TGF-β1)and vascular endothelial growth factor(VEGF)in patients with non-small cell lung cancer(NSCLC)after single-port thoracoscopic radical resection.Methods A total of 50 patients with NSCLC who underwent single-port thoracoscopic radical resection in Affiliated Hospital of Xuzhou Medical University from May 2018 to May 2020 were selected as the observation objects.Serum TGF-β1,VEGF levels and Karnofsky functional status(KPS)scores before and after surgery were compared,and the total incidence of complications was calculated.All subjects were followed up for 3 years,and serum levels of TGF-β1,VEGF and KPS scores were compared between relapsed group and non-relapsed group,survival group and death group.Pearson correlation analysis was used to explore the correlation between TGF-β1,VEGF and KPS scores.The receiver operator characteristic(ROC)curve was plotted and the area under the curve(AUC)was calculated to evaluate the predictive value of serum TGF-β1 and VEGF alone and combined detection in patients with NSCLC after single-port thoracoscopic radical resection.Results The serum levels of TGF-β1 and VEGF were(7.16±1.94)μg/L and(42.26±5.04)ng/L in 50 patients with NSCLC one month after single-port thoracoscopic radical resection,which were lower than those before surgery[(13.62±3.52)μg/L and(136.52±20.66)ng/L,t=11.37,P<0.001;t=31.34,P<0.001].The KPS score one month after surgery was 66.57±8.11,which was higher than that before surgery(53.62±5.62,t=9.28,P<0.001).Postoperative wound healing was delayed in 1 of the 50 patients,pulmonary infection in 1 patient,and no pulmonary embolism and other complications occurred.The total incidence of complications was 4.00%.The serum levels of TGF-β1 and VEGF in patients in the relapsed group(n=6)were(12.95±4.26)μg/L and(72.46±6.05)ng/L respectively,which were higher than those in the non-relapsed group(n=44)[(6.37±1.25)μg/L and(38.14±5.37)ng/L;t=8.34,P<0.001;t=29.99,P<0.001].The KPS score in the relapsed group was 52.16±8.16,which was lower than that in the non-relapsed group(67.55±12.67,t=2.88,P=0.006).Serum levels of TGF-β1 and VEGF in the death group(n=5)were(13.99± 6.82)μg/L and(75.95±9.05)ng/L,which were higher than those in the survival group(n=45)[(6.41± 3.06)μg/L and(38.52±8.37)ng/L;t=4.56,P<0.001;t=21.47,P<0.001].The KPS score in the death group was 1.25±0.34,which was lower than that in the survival group(65.11±12.94,t=10.93,P<0.001).Pearson correlation analysis showed that serum levels of TGF-β1(r=-0.45,P<0.001)and VEGF(r=-0.48,P<0.001)were negatively correlated with KPS scores.ROC curve analysis showed that when the optimal cut-off value of TGF-β1 was 8.14 μg/L,the AUC for predicting recurrence after single-port thoracoscopic radical resection was 0.516(95%CI:0.446-0.676),the sensitivity was 71.85%,and the specificity was 80.69%.When the optimal cut-off value of VEGF was 142 ng/L,the AUC was 0.659(95%CI:0.534-0.761),the sensitivity was 76.04%,and the specificity was 82.52%.The AUC of the combined detection was 0.828(95%CI:0.786-0.951),the sensitivity was 91.86%,and the specificity was 87.52%.The AUC of combined detection was higher than that of serum TGF-β1(Z=2.63,P=0.007),VEGF(Z=2.32,P=0.013)single detection.Conclusion The serum levels of TGF-β1 and VEGF are significantly decreased in NSCLC patients after one month of single-port thoracoscopic radical resection,and the combined detection of the two has predictive value for recurrence after single-port thoracoscopic radical resection.

Transforming growth factor beta1Vascular endothelial growth factorsCarcinoma,non-small-cell lungTreatment outcomeSingle-port thoracoscopic radical surgery

王昆、周中新、臧其威

展开 >

徐州医科大学附属医院心胸外科,徐州 221000

转化生长因子β1 血管内皮生长因子 癌,非小细胞肺 治疗结果 单孔胸腔镜根治术

江苏省卫生健康委高层次拔尖人才科研项目

LGY2020072

2024

国际肿瘤学杂志
中华医学会,山东省医学科学院

国际肿瘤学杂志

CSTPCD
影响因子:0.317
ISSN:1673-422X
年,卷(期):2024.51(4)